Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder.
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.
Quantifying Missing Heritability at Known GWAS Loci.
Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.
A comparison of multiple patient reported outcome measures in identifying major depressive disorder in people with multiple sclerosis.
Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients.
Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis.
Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.
Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls.
n-3 PUFAs Reduce T-Helper 17 Differentiation by Decreasing Responsiveness to Interleukin-6 in Isolated Splenic Mouse CD4+ T Cells.
Acute optic neuritis: Unmet clinical needs and model for new therapies.
Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
EAE is not a useful model for demyelinating disease.
Characterising aggressive multiple sclerosis.
Modeling disease severity in multiple sclerosis using electronic health records.
Myeloradicular Form of Neuroschistosomiasis in a Six-Year-Old Boy Infected With Schistosoma mansoni.
A case of exacerbated multiphasic disseminated encephalomyelitis after interferon beta treatment.
[Acute disseminated encephalomyelitis (ADEM): its diagnostic criteria and therapy].
A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya® (PASSOS)
Mapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients.
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Lead Candidate (MIS416) Overview
Aerobic Fitness Is Associated with Inhibitory Control in Persons with Multiple Sclerosis.

Pages